|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss before allocation to noncontrolling interest | |||||
| Adjustments to reconcile net loss before noncontrolling interest to cash used in operating activities: | |||||
| Depreciation | |||||
| Gain on sale of Nano | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Amortization of debt commitment fee | |||||
| Write off of unamortized debt issuance costs | |||||
| Loss on disposal/sale of property and equipment | |||||
| Induced conversion expense on convertible notes | |||||
| Loss (gain) on remeasurement of warrant liabilities | |||||
| Stock-based compensation | |||||
| Non-cash interest expense | |||||
| Non-cash interest income | |||||
| Loss from equity method investment | |||||
| Paid-in-kind ("PIK") interest expense | |||||
| Issuance of common stock for commitment shares | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Inventory | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease right-of-use assets and operating lease liabilities | |||||
| Contract liabilities | |||||
| Other assets and liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Capital advances to Ligado | |||||
| Purchase of spectrum intangibles | |||||
| Proceeds from sale of Nano, net of cash deconsolidated and transaction costs | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from debt | |||||
| Repayments of debt | |||||
| Payment for debt issuance costs | |||||
| Proceeds from issuance of common stock | |||||
| Payments for third party equity issuance costs | |||||
| Proceeds from warrant exercises | |||||
| Issuance of equity under employee stock plan | |||||
| Employee taxes paid for stock-based compensation awards | |||||
| Purchase of capped call transactions | |||||
| Proceeds from capped call sales | |||||
| Payments for debt commitment fee | |||||
| Proceeds from share issuances to repurchase 2032 4.25% Convertible Notes | |||||
| Payments for repurchase of 2032 4.25% Convertible Notes | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash beginning of period | |||||
| Cash, cash equivalents and restricted cash end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Non-cash activities: | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Purchases of property and equipment in accounts payable and accrued expenses | |||||
| PIK interest paid through issuance of PIK notes | |||||
| Deferred asset acquisition costs paid by issuance of penny warrants | |||||
| Spectrum intangibles acquisition costs accrued or paid by issuance of shares | |||||
| 2034 Convertible Notes settled by issuance of Class A Common Stock | |||||
| Settlement of warrant liabilities by issuing shares | |||||
| Acquisition of equity investment in and loan receivable from SatCo by contributing exclusive distribution rights | |||||
| Interest | |||||
| Income taxes, net | |||||
Loading...